HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lorena Lupinacci Selected Research

Therapeutics

1/2022Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lorena Lupinacci Research Topics

Disease

8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 01/2018
3Neoplasms (Cancer)
01/2023 - 11/2019
1Exanthema (Rash)
01/2022

Drug/Important Bio-Agent (IBA)

4NivolumabIBA
01/2023 - 11/2019
3B7-H1 AntigenIBA
01/2023 - 11/2019
3IpilimumabIBA
01/2023 - 11/2019
2durvalumabIBA
11/2023 - 01/2022
2Immune Checkpoint InhibitorsIBA
11/2023 - 06/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022
1CrizotinibIBA
01/2018

Therapy/Procedure

3Drug Therapy (Chemotherapy)
01/2023 - 01/2020
2Immunotherapy
01/2023 - 01/2020
1Radiotherapy
01/2022
1Therapeutics
01/2022